ABBV Options Signal: Why $262.50 Calls and $242 Support Define Today’s Trade

• Current Price: $242.85 (Down 0.92% intraday)
• Key Resistance: $262.50 (Heavy OTM Call Open Interest)
• Key Support: $242.24 (Lower Bollinger Band)
• Sentiment: Cautiously Bearish Short-Term, Bullish Long-Term

ABBV is sitting right on the edge of a decision. The stock opened strong at $245.87 but has since drifted lower, testing the lower bounds of its trading range. If you’re watching the options chain, the story isn’t about panic selling—it’s about a battle between short-term uncertainty and long-term conviction. The data suggests that while traders are hedging against a dip, they aren’t betting on a collapse. Instead, they are positioning for a potential squeeze upward, provided the stock can hold its current support levels.

Let’s look at where the money is actually sitting. The options market is screaming that $242 is a hard floor. Look at the lower Bollinger Band, which sits at $242.24. The stock is currently trading at $242.85, practically hugging this line. But more importantly, look at the Put Open Interest. For this Friday’s expiration, there is significant Put Open Interest at $135, $145, and $140. These are deep out-of-the-money strikes. Traders aren’t buying puts because they expect a crash; they’re buying them as cheap insurance. It’s like buying a fire extinguisher for a house that isn’t on fire. It’s a hedge, not a directional bet.

On the flip side, the Call side tells a different story. The highest Open Interest for Calls this Friday is at the $262.50 strike, with 1,090 contracts. That’s a massive amount of open interest for a strike that is nearly $20 away from the current price. Next week, we see heavy Call OI at $265 and $257.50. This distribution suggests that institutional players see $262.50 as a major resistance level that needs to be absorbed before any real breakout can happen. They are willing to wait. They are setting up a call wall.

There were no significant block trades today, which is actually a good sign. It means there’s no single whale dumping shares or buying a huge block of calls. The movement is organic, driven by broader market sentiment and the recent earnings news. The Put/Call Open Interest ratio stands at 0.8357. Since this is less than 1, it indicates that more capital is flowing into Calls than Puts. In a falling stock, this is often a contrarian bullish signal. Smart money is accumulating upside exposure while retail traders might be worried about the short-term dip.

The fundamental backdrop is a mix of good and bad. AbbVieABBV-- just reported strong Q2 2026 results, with revenue up 10.2% and Skyrizi/Rinvoq continuing their double-digit growth. That’s great. But the market is focused on the negative: the lowered full-year EPS guidance to $13.97 due to the Apogee Therapeutics acquisition. Investors are nervous about the dilution. They’re also watching the $8 billion debt sale to fund the deal. When you add debt, you add risk, even if the company is stable.

However, the news isn’t all gloom. The FDA accepted the sBLA for BOTOX Cosmetic to treat masseter muscle prominence. This is a new growth vector for the aesthetics division. It’s a long-term positive, but it doesn’t fix today’s price action. The market is currently punishing the stock for the guidance cut, ignoring the pipeline wins. This disconnect creates an opportunity. If the stock stabilizes here, the news flow will likely turn positive again as the Apogee integration details become clearer.

So, what do you do with this? You don’t chase the drop. You wait for the bounce or the breakdown. Here is how I’m looking at the trades:

• Stock Entry: The immediate support is the lower Bollinger Band at $242.24. If the stock holds this level and bounces, consider a long entry near $242.50. The stop loss should be tight, just below $242.00. If it breaks below $242, the next major support is the 200-day moving average cluster around $224–$225. That’s too far away for a quick trade, so if $242 breaks, wait.
• Bullish Call Strategy: If you believe the stock will reclaim $245 and push toward resistance, look at the next Friday expiration. ABBV20260814C257.5ABBV20260814C257.5 has 415 contracts of Open Interest. It’s closer to the money than the $262.50 strike and offers better leverage if the stock breaks above the 30-day moving average at $251.20. A target for this trade would be $260–$262, where the heavy call wall sits.
• Bearish Hedge Strategy: If you think the Apogee dilution fears will persist and the stock rolls over, don’t sell the stock. Buy protection. Look at ABBV20260814P180ABBV20260814P180. It has the highest Open Interest (1,907 contracts) for next week. It’s far out of the money, so it’s cheap. If the stock crashes, this put will gain value. It’s a cheap insurance policy against a deeper correction.

The volatility on the horizon is real, but it’s not chaotic. The stock is ranging, not crashing. The key is patience. The heavy Call OI at $262.50 acts as a magnet and a wall. If ABBVABBV-- can clear $251.20 (the 30-day MA), the path to $262 becomes much clearer. Until then, expect chop. The options market is telling us that downside risk is limited (hence the cheap, deep OTM puts) and upside potential is capped by the call wall. Trade the range, respect the support at $242, and keep an eye on that $262.50 strike. It’s the pivot point for the next month.